Intent to Sole Source - Modeling Sex-Specific Radiation and Chemotherapy Responses in a Bone Marrow Chip Research

The U.S. Food and Drug Administration (FDA) intends to award a sole source, cost reimbursement, no fee contract to President and Fellows of Harvard College, 25 Shattuck Street, Boston MA 02115-6027, under the authority of FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.

President and Fellows of Harvard College will provide Modeling Sex-Specific Radiation and Chemotherapy Responses in a Bone Marrow Chip Research for the U.S. FDA, Office of the Chief Scientist, Office of Counterterrorism and Emerging Threats (OCET). OCET has determined current research in relation to the "Organ-on-Chips Tools for Testing of Radiation Countermeasures" is a direct follow-on to the existing protocol and must utilize the same equipment (Organ Chips), protocols, procedures, and expertise in order to ensure that results are comparable with the body of work currently being performed; ensuring consistency and integrity of the overall study.
This notice is being published in accordance with Federal Acquisition Regulation (FAR) Part 5.101(a)(2) requiring the dissemination of information on proposed contract actions. This is a notice of intent to award a sole-source contract and is not a request for competitive proposals. The statutory authority for this sole-source procurement is FAR 6.302-1.
This notice of intent is not a request for competitive proposals. Interested parties that believes it can meet the requirement, may submit a capability statement to Mrs. Jennifer Johnson at jennifer.johnson3@fda.hhs.gov before September 10, 2018 at 12:00 pm Central Standard Time (CST). A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. If no responsive statements are received before the closing date and time, an award will subsequently be made to President and Fellows of Harvard College. No telephonic inquiries.

.